Revvity Price to Free Cash Flow Ratio 2012-2026 | RVTY
Historical price to free cash flow ratio values for Revvity (RVTY) since 2012.
| Revvity Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-09-15 | 140.19 | 27.95 | |
| 2026-06-30 | 111.19 | $5.02 | 22.17 |
| 2026-03-31 | 87.49 | $4.37 | 20.02 |
| 2025-12-31 | 96.56 | $4.37 | 22.10 |
| 2025-09-30 | 87.41 | $4.24 | 20.64 |
| 2025-06-30 | 96.38 | $4.19 | 23.00 |
| 2025-03-31 | 105.35 | $4.29 | 24.54 |
| 2024-12-31 | 111.07 | $4.41 | 25.19 |
| 2024-09-30 | 127.06 | $4.57 | 27.78 |
| 2024-06-30 | 104.23 | $3.09 | 33.76 |
| 2024-03-31 | 104.29 | $0.79 | 131.49 |
| 2023-12-31 | 108.50 | $0.08 | 1366.54 |
| 2023-09-30 | 109.81 | $-0.46 | 0.00 |
| 2023-06-30 | 117.77 | $1.21 | 97.60 |
| 2023-03-31 | 132.04 | $3.01 | 43.83 |
| 2022-12-31 | 138.87 | $4.70 | 29.55 |
| 2022-09-30 | 119.10 | $6.35 | 18.74 |
| 2022-06-30 | 140.70 | $7.53 | 18.68 |
| 2022-03-31 | 172.52 | $9.30 | 18.56 |
| 2021-12-31 | 198.75 | $11.35 | 17.50 |
| 2021-09-30 | 171.23 | $13.11 | 13.06 |
| 2021-06-30 | 152.50 | $12.43 | 12.26 |
| 2021-03-31 | 126.64 | $11.16 | 11.35 |
| 2020-12-31 | 141.59 | $7.43 | 19.06 |
| 2020-09-30 | 123.77 | $4.89 | 25.31 |
| 2020-06-30 | 96.67 | $3.99 | 24.23 |
| 2020-03-31 | 74.12 | $3.16 | 23.49 |
| 2019-12-31 | 95.54 | $2.58 | 37.03 |
| 2019-09-30 | 83.73 | $1.99 | 42.06 |
| 2019-06-30 | 94.64 | $2.18 | 43.51 |
| 2019-03-31 | 94.59 | $2.41 | 39.31 |
| 2018-12-31 | 77.04 | $2.29 | 33.59 |
| 2018-09-30 | 95.33 | $2.17 | 43.89 |
| 2018-06-30 | 71.70 | $1.61 | 44.48 |
| 2018-03-31 | 74.07 | $1.49 | 49.65 |
| 2017-12-31 | 71.47 | $2.26 | 31.63 |
| 2017-09-30 | 67.34 | $2.71 | 24.83 |
| 2017-06-30 | 66.47 | $2.68 | 24.77 |
| 2017-03-31 | 56.56 | $3.29 | 17.21 |
| 2016-12-31 | 50.74 | $3.08 | 16.47 |
| 2016-09-30 | 54.52 | $2.63 | 20.75 |
| 2016-06-30 | 50.87 | $2.70 | 18.85 |
| 2016-03-31 | 47.93 | $2.22 | 21.59 |
| 2015-12-31 | 51.84 | $2.28 | 22.69 |
| 2015-09-30 | 44.41 | $2.10 | 21.17 |
| 2015-06-30 | 50.80 | $2.11 | 24.02 |
| 2015-03-31 | 49.28 | $2.01 | 24.52 |
| 2014-12-31 | 42.07 | $2.26 | 18.62 |
| 2014-09-30 | 41.88 | $1.99 | 21.00 |
| 2014-06-30 | 44.92 | $2.32 | 19.39 |
| 2014-03-31 | 43.14 | $2.06 | 20.91 |
| 2013-12-31 | 39.41 | $1.51 | 26.04 |
| 2013-09-30 | 36.02 | $1.14 | 31.63 |
| 2013-06-30 | 30.94 | $0.39 | 78.39 |
| 2013-03-31 | 31.96 | $0.86 | 37.27 |
| 2012-12-31 | 30.10 | $0.96 | 31.49 |
| 2012-09-30 | 27.88 | $1.44 | 19.37 |
| 2012-06-30 | 24.34 | $1.72 | 14.14 |
| 2012-03-31 | 26.02 | $1.50 | 17.38 |
| 2011-12-31 | 18.76 | $1.71 | 10.97 |
| 2011-09-30 | 17.95 | $1.19 | 15.03 |
| 2011-06-30 | 25.08 | $0.90 | 27.84 |
| 2011-03-31 | 24.42 | $1.15 | 21.25 |
| 2010-12-31 | 23.94 | $1.20 | 19.94 |
| 2010-09-30 | 21.38 | $1.49 | 14.31 |
| 2010-06-30 | 19.03 | $1.72 | 11.09 |
| 2010-03-31 | 21.94 | $1.33 | 16.53 |
| 2009-12-31 | 18.84 | $1.06 | 17.83 |
| 2009-09-30 | 17.55 | $1.35 | 13.04 |
| 2009-06-30 | 15.80 | $1.22 | 12.90 |
| 2009-03-31 | 11.54 | $1.55 | 7.46 |
| 2008-12-31 | 12.51 | $1.54 | 8.13 |
| 2008-09-30 | 22.38 | $1.52 | 14.71 |
| 2008-06-30 | 24.90 | $1.48 | 16.81 |
| 2008-03-31 | 21.62 | $1.45 | 14.95 |
| 2007-12-31 | 23.13 | $1.42 | 16.31 |
| 2007-09-30 | 25.90 | $1.29 | 20.05 |
| 2007-06-30 | 23.05 | $1.32 | 17.51 |
| 2007-03-31 | 21.36 | $0.97 | 22.11 |
| 2006-12-31 | 19.55 | $0.74 | 26.30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.338B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |